FLUOROURACIL CREAM, 0.5%

FLUOROURACIL CREAM, 0.5% was reported 77616 times

FLUOROURACIL CREAM, 0.5% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DUCTAL ADENOCARCINOMA OF PANCREAS 108 0.3899
1 COLORECTAL CANCER METASTATIC 593 0.2500
2 PORTAL VENOUS GAS 83 0.2287
3 OESOPHAGEAL FISTULA 70 0.2201
4 MUCOSAL TOXICITY 57 0.2103
5 NON-CIRRHOTIC PORTAL HYPERTENSION 77 0.2048
6 TUMOUR PERFORATION 64 0.2013
7 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY 40 0.1878
8 RECTAL CANCER METASTATIC 53 0.1523
9 ARTERIOSPASM CORONARY 591 0.1472
10 SKIN TOXICITY 795 0.1405
11 GASTROINTESTINAL ANASTOMOTIC LEAK 52 0.1333
12 ACUTE PROMYELOCYTIC LEUKAEMIA 131 0.1274
13 ANASTOMOTIC COMPLICATION 43 0.1250
14 ANASTOMOTIC LEAK 85 0.1225
15 HEPATECTOMY 38 0.1214
16 NODULAR REGENERATIVE HYPERPLASIA 76 0.1184
17 DERMATITIS ACNEIFORM 703 0.1154
18 FOCAL NODULAR HYPERPLASIA 58 0.1115
19 BACTERIAL TRANSLOCATION 35 0.1104
20 RECTAL PERFORATION 56 0.1039
21 HYPERAMMONAEMIC ENCEPHALOPATHY 179 0.1029
22 METASTASES TO OVARY 32 0.1003
23 RECTAL ADENOCARCINOMA 58 0.0959
24 CHOLINERGIC SYNDROME 61 0.0956
25 GASTROINTESTINAL TOXICITY 427 0.0888
26 DEVICE RELATED THROMBOSIS 87 0.0882
27 CARBOHYDRATE ANTIGEN 19-9 INCREASED 46 0.0870
28 ADENOCARCINOMA OF COLON 160 0.0853
29 TOXIC LEUKOENCEPHALOPATHY 60 0.0826
30 PARONYCHIA 362 0.0823
31 STEATOHEPATITIS 43 0.0802
32 COLON CANCER METASTATIC 128 0.0794
33 NEUTROPENIC COLITIS 163 0.0787
34 MYOPERICARDITIS 60 0.0769
35 ILEAL PERFORATION 51 0.0769
36 RADIATION SKIN INJURY 87 0.0750
37 INTRAVASCULAR HAEMOLYSIS 41 0.0732
38 MUCOSAL INFLAMMATION 1844 0.0704
39 METASTASES TO PERITONEUM 176 0.0696
40 INTERLEUKIN LEVEL INCREASED 38 0.0688
41 PERIPHERAL SENSORY NEUROPATHY 401 0.0685
42 PORTAL HYPERTENSION 209 0.0677
43 TUMOUR NECROSIS 71 0.0672
44 MYOCARDIAL INJURY 75 0.0667
45 GASTROINTESTINAL PERFORATION 274 0.0658
46 RECALL PHENOMENON 54 0.0646
47 CARCINOEMBRYONIC ANTIGEN INCREASED 123 0.0634
48 PNEUMATOSIS INTESTINALIS 177 0.0620
49 MALIGNANT ASCITES 47 0.0613
50 AORTITIS 42 0.0612
51 ENTEROCUTANEOUS FISTULA 52 0.0590
52 AORTIC THROMBOSIS 68 0.0588
53 SUBCLAVIAN VEIN THROMBOSIS 67 0.0588
54 HYPERAMMONAEMIA 294 0.0587
55 ADMINISTRATION SITE EXTRAVASATION 57 0.0571
56 CARDIOTOXICITY 508 0.0569
57 BILIARY TRACT INFECTION 35 0.0563
58 NEUTROPENIC SEPSIS 398 0.0557
59 GRANULOCYTE COUNT DECREASED 102 0.0550
60 NEUROTOXICITY 963 0.0549
61 POLYNEUROPATHY 657 0.0548
62 HAEMATOTOXICITY 517 0.0544
63 PERITONEAL DISORDER 35 0.0540
64 METASTASES TO LIVER 940 0.0534
65 PULMONARY ARTERY THROMBOSIS 41 0.0534
66 VENOOCCLUSIVE LIVER DISEASE 261 0.0528
67 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 41 0.0524
68 ENTEROVESICAL FISTULA 39 0.0514
69 METASTASES TO SKIN 53 0.0513
70 SYSTEMIC SCLERODERMA 37 0.0508
71 ENTERITIS 325 0.0507
72 PRINZMETAL ANGINA 50 0.0503
73 CATHETER RELATED COMPLICATION 56 0.0497
74 ADENOCARCINOMA GASTRIC 46 0.0495
75 CATHETER RELATED INFECTION 50 0.0494
76 LYMPHANGIOSIS CARCINOMATOSA 51 0.0489
77 DUODENAL PERFORATION 48 0.0489
78 SYSTEMIC INFECTION 80 0.0482
79 METASTASES TO LUNG 556 0.0481
80 DIFFUSE ALVEOLAR DAMAGE 55 0.0478
81 OESOPHAGEAL PERFORATION 39 0.0468
82 PELVIC ABSCESS 53 0.0461
83 PERFORATION 37 0.0459
84 HYPOMAGNESAEMIA 638 0.0458
85 JUGULAR VEIN THROMBOSIS 81 0.0455
86 ADENOCARCINOMA 102 0.0455
87 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 150 0.0452
88 THERAPY PARTIAL RESPONDER 706 0.0452
89 METASTASES TO PLEURA 47 0.0448
90 FEBRILE NEUTROPENIA 2915 0.0439
91 LARYNGOSPASM 118 0.0438
92 VASOSPASM 40 0.0435
93 NEUTROPENIC INFECTION 41 0.0428
94 OCULAR TOXICITY 47 0.0426
95 RECTAL TENESMUS 53 0.0425
96 LEUKOENCEPHALOPATHY 155 0.0416
97 GASTROINTESTINAL NECROSIS 121 0.0415
98 SUBRETINAL FLUID 45 0.0412
99 VENA CAVA THROMBOSIS 68 0.0409
100 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 949 0.0407
101 BONE MARROW TOXICITY 47 0.0397
102 GASTROINTESTINAL STOMA COMPLICATION 62 0.0394
103 NEUTROPENIA 5292 0.0389
104 MYELOSUPPRESSION 1387 0.0385
105 SUBILEUS 80 0.0384
106 ACUTE ABDOMEN 56 0.0381
107 LARGE INTESTINE PERFORATION 265 0.0381
108 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 47 0.0377
109 METASTASES TO LYMPH NODES 254 0.0376
110 CHOLANGITIS 232 0.0374
111 NEUROPATHY PERIPHERAL 3541 0.0372
112 BONE MARROW DEPRESSION 36 0.0369
113 TROPONIN I INCREASED 61 0.0366
114 PERIPHERAL MOTOR NEUROPATHY 51 0.0364
115 PANCREATIC CARCINOMA METASTATIC 100 0.0351
116 STREPTOCOCCAL BACTERAEMIA 38 0.0349
117 SMALL INTESTINAL PERFORATION 65 0.0346
118 ENTEROCOLITIS 199 0.0344
119 CARDIAC VENTRICULAR THROMBOSIS 44 0.0341
120 XEROSIS 42 0.0339
121 LIVER ABSCESS 110 0.0339
122 INTESTINAL ISCHAEMIA 186 0.0337
123 STOMA SITE HAEMORRHAGE 52 0.0337
124 FEBRILE BONE MARROW APLASIA 143 0.0336
125 STRESS CARDIOMYOPATHY 194 0.0333
126 HYPOALBUMINAEMIA 258 0.0331
127 AZOTAEMIA 132 0.0330
128 LEUKOPENIA 1640 0.0328
129 LARGE INTESTINAL OBSTRUCTION 73 0.0326
130 IMMUNE-MEDIATED HEPATIC DISORDER 63 0.0323
131 GASTRIC PERFORATION 88 0.0323
132 THROMBOCYTOPENIC PURPURA 44 0.0322
133 LEFT VENTRICULAR DYSFUNCTION 214 0.0319
134 TUMOUR HAEMORRHAGE 90 0.0315
135 RASH PUSTULAR 229 0.0314
136 ORAL INTAKE REDUCED 76 0.0314
137 ONYCHOLYSIS 49 0.0313
138 OESOPHAGEAL VARICES HAEMORRHAGE 68 0.0313
139 PERIPHERAL SENSORIMOTOR NEUROPATHY 39 0.0310
140 BONE MARROW FAILURE 627 0.0308
141 TUMOUR LYSIS SYNDROME 270 0.0307
142 METASTASIS 218 0.0305
143 PORTAL VEIN THROMBOSIS 97 0.0300
144 EXTRAVASATION 123 0.0299
145 OESOPHAGEAL STENOSIS 85 0.0299
146 VARICES OESOPHAGEAL 90 0.0297
147 ACUTE CORONARY SYNDROME 245 0.0296
148 GENE MUTATION 58 0.0293
149 NEUTROPHIL COUNT DECREASED 1192 0.0292
150 CUTANEOUS LUPUS ERYTHEMATOSUS 56 0.0288
151 APLASIA 56 0.0286
152 IMMUNE-MEDIATED LUNG DISEASE 52 0.0285
153 EMBOLISM ARTERIAL 34 0.0283
154 NEOPLASM PROGRESSION 979 0.0281
155 RECTAL CANCER 86 0.0280
156 IMMUNE-MEDIATED MYOCARDITIS 45 0.0278
157 DISEASE PROGRESSION 3293 0.0278
158 RESPIRATORY ALKALOSIS 45 0.0277
159 INTESTINAL PERFORATION 307 0.0273
160 VENOUS THROMBOSIS 107 0.0272
161 THROMBOCYTOPENIA 3037 0.0271
162 PNEUMOPERITONEUM 50 0.0270
163 CACHEXIA 139 0.0270
164 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 48 0.0270
165 PROTEINURIA 513 0.0270
166 HYPERBILIRUBINAEMIA 279 0.0269
167 ILEUS 333 0.0268
168 ADENOCARCINOMA PANCREAS 34 0.0265
169 PHARYNGEAL INFLAMMATION 32 0.0263
170 SECOND PRIMARY MALIGNANCY 218 0.0262
171 NEUTROPHIL COUNT ABNORMAL 73 0.0258
172 FEMALE GENITAL TRACT FISTULA 44 0.0257
173 HEPATIC LESION 111 0.0256
174 INFECTIOUS PLEURAL EFFUSION 39 0.0256
175 STOMATITIS 1537 0.0253
176 INTERSTITIAL LUNG DISEASE 1204 0.0248
177 VENTRICULAR HYPOKINESIA 78 0.0243
178 PROCTITIS 68 0.0243
179 ESCHERICHIA BACTERAEMIA 57 0.0242
180 BLOOD CULTURE POSITIVE 72 0.0240
181 HYPOKALAEMIA 1104 0.0239
182 HAEMOLYTIC URAEMIC SYNDROME 55 0.0237
183 MALIGNANT PLEURAL EFFUSION 40 0.0237
184 ACUTE MYELOID LEUKAEMIA 369 0.0237
185 NEOPLASM RECURRENCE 80 0.0236
186 NEUROPATHY 40 0.0235
187 VENTRICULAR DYSFUNCTION 61 0.0235
188 LYMPHADENOPATHY MEDIASTINAL 45 0.0235
189 EMBOLISM 195 0.0235
190 WOUND DEHISCENCE 79 0.0234
191 DISSEMINATED INTRAVASCULAR COAGULATION 329 0.0233
192 OESOPHAGITIS 255 0.0233
193 NECROTISING FASCIITIS 80 0.0227
194 DYSENTERY 42 0.0225
195 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 215 0.0225
196 HYPOVOLAEMIC SHOCK 107 0.0223
197 DYSAESTHESIA 68 0.0222
198 HYPERTRANSAMINASAEMIA 154 0.0221
199 IMMUNE THROMBOCYTOPENIA 101 0.0220
200 HICCUPS 179 0.0218
201 MALIGNANT NEOPLASM PROGRESSION 2216 0.0216
202 ORGANISING PNEUMONIA 106 0.0214
203 ABDOMINAL ABSCESS 94 0.0212
204 IMMUNE-MEDIATED ENTEROCOLITIS 76 0.0206
205 CARDIOMYOPATHY 305 0.0206
206 IMMUNE-MEDIATED HEPATITIS 42 0.0205
207 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 45 0.0205
208 INCORRECT DRUG ADMINISTRATION RATE 87 0.0204
209 ODYNOPHAGIA 122 0.0204
210 CONGESTIVE CARDIOMYOPATHY 85 0.0204
211 ABDOMINAL INFECTION 52 0.0203
212 EJECTION FRACTION DECREASED 314 0.0202
213 ARTERIAL THROMBOSIS 39 0.0202
214 STRIDOR 59 0.0200
215 PROCTALGIA 127 0.0197
216 SMALL INTESTINAL OBSTRUCTION 243 0.0197
217 RADIATION PNEUMONITIS 42 0.0196
218 ASCITES 573 0.0195
219 EMBOLISM VENOUS 59 0.0194
220 METASTASES TO BONE 318 0.0194
221 BLOOD ALBUMIN DECREASED 151 0.0190
222 ILEUS PARALYTIC 84 0.0188
223 BREAST CANCER RECURRENT 59 0.0187
224 PULMONARY INFARCTION 44 0.0186
225 FIXED ERUPTION 32 0.0186
226 METASTASES TO MENINGES 42 0.0185
227 ELECTROLYTE IMBALANCE 213 0.0183
228 TETANY 33 0.0181
229 PULMONARY TOXICITY 128 0.0181
230 SEPTIC SHOCK 785 0.0180
231 LICHENOID KERATOSIS 41 0.0179
232 VENOUS THROMBOSIS LIMB 37 0.0179
233 METASTATIC NEOPLASM 77 0.0178
234 VOCAL CORD PARALYSIS 32 0.0178
235 NEPHROTIC SYNDROME 122 0.0178
236 HYPOVOLAEMIA 103 0.0176
237 JAUNDICE CHOLESTATIC 62 0.0175
238 PSEUDOMEMBRANOUS COLITIS 39 0.0174
239 DUODENAL ULCER 123 0.0174
240 MULTIPLE-DRUG RESISTANCE 54 0.0174
241 HYPERTHERMIA 131 0.0171
242 PERFORMANCE STATUS DECREASED 80 0.0171
243 HEPATIC MASS 33 0.0171
244 SPLENOMEGALY 200 0.0171
245 CAPILLARY LEAK SYNDROME 35 0.0169
246 BREAST CANCER METASTATIC 180 0.0167
247 THROMBOTIC THROMBOCYTOPENIC PURPURA 59 0.0167
248 ELECTROCARDIOGRAM T WAVE INVERSION 37 0.0167
249 CLOSTRIDIAL INFECTION 56 0.0165
250 ANAPHYLACTOID REACTION 68 0.0165
251 HYDRONEPHROSIS 123 0.0164
252 ANAL HAEMORRHAGE 46 0.0164
253 DRUG TOXICITY 223 0.0164
254 METASTASES TO SPINE 55 0.0163
255 IMMUNE THROMBOCYTOPENIC PURPURA 46 0.0163
256 LUNG CONSOLIDATION 45 0.0161
257 HAEMOLYTIC ANAEMIA 144 0.0161
258 COMPUTERISED TOMOGRAM ABNORMAL 36 0.0159
259 BLOOD CREATINE INCREASED 70 0.0158
260 MYOCARDITIS 180 0.0157
261 THROMBOPHLEBITIS 55 0.0157
262 PERIPHERAL ISCHAEMIA 64 0.0157
263 KLEBSIELLA INFECTION 79 0.0156
264 GUILLAIN-BARRE SYNDROME 75 0.0155
265 FAILURE TO THRIVE 80 0.0154
266 GASTROINTESTINAL OBSTRUCTION 37 0.0154
267 OESOPHAGEAL CANDIDIASIS 61 0.0153
268 MYOCARDIAL ISCHAEMIA 174 0.0153
269 DEAFNESS NEUROSENSORY 50 0.0152
270 PNEUMONITIS 412 0.0151
271 BLOOD CHLORIDE DECREASED 39 0.0151
272 NECROSIS 84 0.0151
273 INVASIVE DUCTAL BREAST CARCINOMA 41 0.0151
274 HYPOCALCAEMIA 285 0.0150
275 CARDIAC FAILURE ACUTE 100 0.0150
276 RED CELL DISTRIBUTION WIDTH INCREASED 62 0.0149
277 PULMONARY EMBOLISM 1416 0.0149
278 HYPERPYREXIA 63 0.0149
279 COLON CANCER 219 0.0147
280 TOXIC ENCEPHALOPATHY 74 0.0146
281 VENTRICULAR FIBRILLATION 161 0.0145
282 DEVICE RELATED INFECTION 223 0.0145
283 INTESTINAL OBSTRUCTION 543 0.0144
284 COLITIS ISCHAEMIC 97 0.0144
285 PANCYTOPENIA 803 0.0144
286 SUDDEN DEATH 152 0.0144
287 SKIN REACTION 202 0.0143
288 COLITIS 542 0.0143
289 CARDIOGENIC SHOCK 203 0.0141
290 COLITIS MICROSCOPIC 67 0.0141
291 ANOREXIA 182 0.0141
292 ACUTE RESPIRATORY DISTRESS SYNDROME 248 0.0140
293 METABOLIC ENCEPHALOPATHY 42 0.0140
294 HEPATIC CYTOLYSIS 177 0.0139
295 METASTASES TO CENTRAL NERVOUS SYSTEM 178 0.0138
296 SQUAMOUS CELL CARCINOMA OF SKIN 83 0.0137
297 DEVICE INFUSION ISSUE 34 0.0137
298 GRANULOCYTOPENIA 78 0.0137
299 ANAEMIA 2609 0.0137
300 LUNG OPACITY 36 0.0136
301 PERITONITIS 281 0.0136
302 SUSPECTED OFF LABEL USE 61 0.0135
303 MALNUTRITION 151 0.0135
304 CATHETER SITE INFECTION 51 0.0135
305 LARYNGEAL OEDEMA 83 0.0135
306 HEPATIC FIBROSIS 46 0.0134
307 LEUKOCYTOSIS 242 0.0134
308 FISTULA 150 0.0133
309 HEPATITIS B 80 0.0133
310 BACTERAEMIA 155 0.0130
311 DERMATOMYOSITIS 33 0.0130
312 SHOCK HAEMORRHAGIC 106 0.0130
313 DEHYDRATION 1726 0.0129
314 HYPERTENSIVE CRISIS 143 0.0128
315 ISCHAEMIA 59 0.0128
316 OESOPHAGEAL ULCER 49 0.0127
317 PULMONARY FIBROSIS 244 0.0127
318 CHOLESTASIS 242 0.0126
319 SEPSIS 1402 0.0126
320 TUMOUR MARKER INCREASED 60 0.0125
321 TROPONIN INCREASED 95 0.0125
322 HYPOPHOSPHATAEMIA 92 0.0124
323 CEREBRAL ISCHAEMIA 64 0.0124
324 GENERAL PHYSICAL HEALTH DETERIORATION 1438 0.0124
325 CYTOPENIA 150 0.0122
326 HEPATIC ENCEPHALOPATHY 114 0.0122
327 PAPILLOEDEMA 55 0.0122
328 BLOOD LACTIC ACID INCREASED 64 0.0121
329 THROMBOTIC MICROANGIOPATHY 118 0.0121
330 AGRANULOCYTOSIS 225 0.0121
331 HYPOPHAGIA 309 0.0121
332 BLOOD ALKALINE PHOSPHATASE INCREASED 300 0.0121
333 TONGUE OEDEMA 46 0.0120
334 HYPERNATRAEMIA 60 0.0120
335 CHOLECYSTITIS ACUTE 68 0.0120
336 PIGMENTATION DISORDER 74 0.0120
337 ACUTE PULMONARY OEDEMA 67 0.0119
338 ENCEPHALOPATHY 293 0.0119
339 DEEP VEIN THROMBOSIS 773 0.0119
340 DUODENAL ULCER HAEMORRHAGE 34 0.0119
341 HEPATIC FAILURE 357 0.0118
342 HYPERTRIGLYCERIDAEMIA 69 0.0118
343 NAIL DISORDER 103 0.0118
344 PROTEIN TOTAL DECREASED 44 0.0117
345 ABDOMINAL TENDERNESS 58 0.0117
346 ANAL FISTULA 62 0.0116
347 PHLEBITIS 59 0.0115
348 BLOOD CREATININE DECREASED 36 0.0115
349 WHITE BLOOD CELL COUNT ABNORMAL 73 0.0114
350 SUPRAVENTRICULAR TACHYCARDIA 109 0.0114
351 RENAL TUBULAR DISORDER 32 0.0114
352 LEFT VENTRICULAR FAILURE 39 0.0113
353 TOXIC SKIN ERUPTION 114 0.0113
354 FAECALOMA 62 0.0113
355 LYMPHOPENIA 160 0.0113
356 MULTI-ORGAN FAILURE 195 0.0113
357 MYELODYSPLASTIC SYNDROME 163 0.0113
358 SUPRAVENTRICULAR EXTRASYSTOLES 38 0.0112
359 VASCULAR DEVICE INFECTION 51 0.0112
360 DERMATITIS 235 0.0112
361 DERMATITIS EXFOLIATIVE GENERALISED 39 0.0112
362 ORAL CANDIDIASIS 147 0.0112
363 OLIGURIA 69 0.0111
364 DUODENITIS 34 0.0111
365 TYPE I HYPERSENSITIVITY 39 0.0111
366 INTRACARDIAC THROMBUS 34 0.0111
367 DIARRHOEA HAEMORRHAGIC 103 0.0110
368 DIARRHOEA 7076 0.0110
369 BLOOD PHOSPHORUS DECREASED 40 0.0109
370 PNEUMOCYSTIS JIROVECII PNEUMONIA 109 0.0108
371 LUNG INFILTRATION 95 0.0107
372 CARDIAC DYSFUNCTION 40 0.0107
373 HYPONATRAEMIA 605 0.0107
374 SCAB 122 0.0107
375 PLEURAL EFFUSION 650 0.0107
376 STAPHYLOCOCCAL BACTERAEMIA 46 0.0106
377 WHITE BLOOD CELL COUNT DECREASED 1146 0.0106
378 RECURRENT CANCER 43 0.0105
379 PULMONARY ALVEOLAR HAEMORRHAGE 59 0.0105
380 AUTOIMMUNE HAEMOLYTIC ANAEMIA 36 0.0105
381 CANDIDIASIS 42 0.0105
382 ANAL FISSURE 56 0.0104
383 BACTERIAL SEPSIS 34 0.0104
384 HEPATOTOXICITY 232 0.0104
385 HEPATITIS B REACTIVATION 33 0.0104
386 CONJUNCTIVITIS 192 0.0103
387 TRISMUS 53 0.0103
388 BLOOD BILIRUBIN INCREASED 276 0.0102
389 BLOOD LACTATE DEHYDROGENASE INCREASED 161 0.0102
390 NEPHROPATHY TOXIC 114 0.0101
391 PULSE ABSENT 48 0.0101
392 LUNG NEOPLASM 43 0.0101
393 ACUTE MYOCARDIAL INFARCTION 295 0.0100
394 CHRONIC MYELOID LEUKAEMIA 46 0.0100
395 BRONCHOPNEUMONIA 34 0.0099
396 STAPHYLOCOCCAL SEPSIS 49 0.0099
397 RASH MACULO-PAPULAR 220 0.0099
398 BLOOD MAGNESIUM DECREASED 85 0.0098
399 PNEUMOTHORAX 156 0.0098
400 ACIDOSIS 74 0.0097
401 SKIN NECROSIS 50 0.0096
402 PURULENT DISCHARGE 41 0.0096
403 THROMBOCYTOSIS 35 0.0095
404 HEPATIC FUNCTION ABNORMAL 356 0.0095
405 BLEPHARITIS 38 0.0095
406 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 97 0.0094
407 AORTIC DISSECTION 39 0.0094
408 CORONARY ARTERY STENOSIS 47 0.0093
409 ISCHAEMIC STROKE 166 0.0093
410 PNEUMONIA ASPIRATION 232 0.0093
411 FIBRIN D DIMER INCREASED 33 0.0093
412 FOLLICULITIS 97 0.0092
413 HAEMOLYSIS 71 0.0092
414 CIRCULATORY COLLAPSE 155 0.0091
415 MOUTH ULCERATION 191 0.0091
416 DECREASED APPETITE 2094 0.0090
417 PLATELET COUNT DECREASED 960 0.0090
418 SHOCK 207 0.0090
419 RESPIRATORY FAILURE 656 0.0090
420 SPINAL CORD COMPRESSION 35 0.0090
421 SINUS TACHYCARDIA 127 0.0089
422 PYREXIA 3086 0.0089
423 TEMPERATURE INTOLERANCE 92 0.0089
424 BLOOD UREA INCREASED 149 0.0089
425 APHTHOUS ULCER 69 0.0089
426 SARCOIDOSIS 42 0.0088
427 HEPATITIS CHOLESTATIC 53 0.0088
428 ORAL PAIN 197 0.0088
429 ATELECTASIS 85 0.0088
430 ELECTROCARDIOGRAM ABNORMAL 69 0.0088
431 SKIN FISSURES 171 0.0087
432 ANGIOPATHY 49 0.0087
433 BLOOD CREATININE INCREASED 569 0.0087
434 GAMMA-GLUTAMYLTRANSFERASE INCREASED 193 0.0087
435 RESPIRATORY DISTRESS 240 0.0087
436 RENAL FAILURE ACUTE 368 0.0087
437 RENAL TUBULAR NECROSIS 85 0.0087
438 RALES 50 0.0086
439 TACHYPNOEA 117 0.0086
440 PURPURA 76 0.0086
441 VOMITING 4037 0.0086
442 HYPERURICAEMIA 35 0.0085
443 JAUNDICE 229 0.0085
444 MYOSITIS 76 0.0085
445 NEUTROPHILIA 48 0.0084
446 ASPARTATE AMINOTRANSFERASE INCREASED 442 0.0083
447 MELAENA 183 0.0083
448 VENTRICULAR TACHYCARDIA 137 0.0083
449 DERMATITIS BULLOUS 60 0.0083
450 HAEMATOCRIT DECREASED 164 0.0083
451 EPISTAXIS 617 0.0082
452 ABDOMINAL PAIN 1917 0.0082
453 ALTERED STATE OF CONSCIOUSNESS 178 0.0082
454 RECTAL HAEMORRHAGE 352 0.0082
455 PROTHROMBIN TIME PROLONGED 49 0.0082
456 ENDOCARDITIS 42 0.0082
457 TRANSAMINASES INCREASED 181 0.0081
458 CEREBRAL INFARCTION 198 0.0081
459 DYSARTHRIA 305 0.0081
460 CHOLECYSTITIS 96 0.0081
461 ACUTE RESPIRATORY FAILURE 155 0.0080
462 ACUTE KIDNEY INJURY 1232 0.0080
463 PETIT MAL EPILEPSY 41 0.0080
464 CLOSTRIDIUM DIFFICILE COLITIS 85 0.0080
465 DIVERTICULUM INTESTINAL 35 0.0080
466 LOWER GASTROINTESTINAL HAEMORRHAGE 59 0.0080
467 BLOOD SODIUM DECREASED 150 0.0079
468 HYPERGLYCAEMIA 289 0.0079
469 HAEMATEMESIS 200 0.0079
470 ANGINA PECTORIS 225 0.0078
471 INFUSION RELATED REACTION 518 0.0078
472 CHILLS 913 0.0078
473 ALANINE AMINOTRANSFERASE INCREASED 477 0.0078
474 SKIN LESION 211 0.0077
475 HEPATIC STEATOSIS 143 0.0077
476 ANURIA 66 0.0077
477 C-REACTIVE PROTEIN INCREASED 279 0.0077
478 SKIN DISORDER 255 0.0076
479 ANAL ABSCESS 41 0.0076
480 GASTROENTERITIS 111 0.0076
481 SKIN HYPERPIGMENTATION 65 0.0076
482 PANCREATITIS ACUTE 170 0.0076
483 BODY TEMPERATURE INCREASED 154 0.0075
484 BUNDLE BRANCH BLOCK LEFT 32 0.0075
485 HYPOXIA 264 0.0075
486 HAEMOGLOBIN DECREASED 764 0.0074
487 ONYCHOCLASIS 51 0.0074
488 CHEILITIS 40 0.0074
489 ERYTHEMA MULTIFORME 68 0.0073
490 GASTROINTESTINAL INFLAMMATION 56 0.0071
491 BRONCHOSPASM 102 0.0071
492 NEUTROPHIL COUNT INCREASED 73 0.0071
493 RENAL IMPAIRMENT 594 0.0071
494 TACHYCARDIA 628 0.0071
495 REFUSAL OF TREATMENT BY PATIENT 46 0.0070
496 WOUND INFECTION 77 0.0070
497 CARDIAC FAILURE 564 0.0070
498 DRUG-INDUCED LIVER INJURY 218 0.0069
499 MULTIPLE ORGAN DYSFUNCTION SYNDROME 196 0.0069
500 COAGULOPATHY 115 0.0069
501 PATHOLOGICAL FRACTURE 35 0.0069
502 ABSCESS 110 0.0069
503 DRUG RESISTANCE 177 0.0069
504 ASTHENIA 2588 0.0069
505 DYSPHAGIA 651 0.0069
506 LYMPHOCYTE COUNT DECREASED 121 0.0068
507 HAEMOGLOBIN ABNORMAL 44 0.0068
508 FEMORAL NECK FRACTURE 35 0.0068
509 BLOOD POTASSIUM DECREASED 205 0.0068
510 FLUID INTAKE REDUCED 34 0.0068
511 PERICARDIAL EFFUSION 157 0.0068
512 ANAPHYLACTIC SHOCK 175 0.0068
513 GASTRIC ULCER 129 0.0068
514 HEPATOCELLULAR INJURY 96 0.0068
515 GASTROINTESTINAL MOTILITY DISORDER 36 0.0067
516 PULMONARY MASS 100 0.0067
517 DISEASE RECURRENCE 319 0.0067
518 PYELONEPHRITIS 58 0.0067
519 ENTEROCOCCAL INFECTION 32 0.0066
520 UROSEPSIS 61 0.0066
521 ULCER 105 0.0066
522 NO THERAPEUTIC RESPONSE 80 0.0066
523 HAEMORRHOIDAL HAEMORRHAGE 32 0.0065
524 PARAESTHESIA 1030 0.0065
525 OSTEONECROSIS OF JAW 162 0.0065
526 METABOLIC DISORDER 38 0.0065
527 TOXIC EPIDERMAL NECROLYSIS 99 0.0065
528 MITRAL VALVE INCOMPETENCE 73 0.0064
529 ESCHERICHIA INFECTION 53 0.0064
530 VASCULITIS 75 0.0064
531 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 53 0.0064
532 BREAST MASS 43 0.0064
533 NAUSEA 5064 0.0064
534 LIPASE INCREASED 49 0.0064
535 GENERALISED OEDEMA 79 0.0064
536 SINUS BRADYCARDIA 61 0.0063
537 ORAL DISORDER 46 0.0063
538 PNEUMONIA BACTERIAL 57 0.0062
539 FLANK PAIN 58 0.0062
540 CYANOSIS 97 0.0062
541 ATRIAL FIBRILLATION 600 0.0062
542 HERPES SIMPLEX 40 0.0061
543 BLINDNESS TRANSIENT 45 0.0061
544 DRUG EXPOSURE DURING PREGNANCY 206 0.0061
545 BLOOD CALCIUM DECREASED 68 0.0060
546 ORTHOSTATIC HYPOTENSION 105 0.0060
547 WHITE BLOOD CELL COUNT INCREASED 231 0.0060
548 HAEMATURIA 206 0.0060
549 HYPOTENSION 1204 0.0060
550 HYPERCALCAEMIA 74 0.0060
551 LIVER INJURY 147 0.0060
552 PARAESTHESIA ORAL 86 0.0060
553 SQUAMOUS CELL CARCINOMA 56 0.0059
554 PETECHIAE 62 0.0059
555 METABOLIC ACIDOSIS 190 0.0059
556 POST PROCEDURAL COMPLICATION 114 0.0059
557 LYMPHADENOPATHY 209 0.0059
558 RENAL FAILURE 779 0.0059
559 GINGIVAL BLEEDING 80 0.0059
560 HYPERKALAEMIA 205 0.0058
561 HEPATITIS 149 0.0058
562 STAPHYLOCOCCAL INFECTION 192 0.0058
563 CARDIO-RESPIRATORY ARREST 243 0.0058
564 CANDIDA INFECTION 98 0.0058
565 PLATELET COUNT ABNORMAL 35 0.0058
566 INFUSION SITE EXTRAVASATION 36 0.0058
567 STATUS EPILEPTICUS 65 0.0057
568 ASPIRATION 63 0.0057
569 ARTERIOSCLEROSIS 54 0.0057
570 HYPERTENSION 1215 0.0057
571 TENDERNESS 59 0.0057
572 GRAND MAL CONVULSION 52 0.0056
573 PALLOR 153 0.0056
574 FOETAL GROWTH RESTRICTION 34 0.0056
575 ARTERIOSCLEROSIS CORONARY ARTERY 37 0.0056
576 APHASIA 168 0.0056
577 TONGUE DISORDER 40 0.0055
578 FACIAL PAIN 49 0.0055
579 VENTRICULAR EXTRASYSTOLES 57 0.0055
580 BACTERIAL INFECTION 102 0.0055
581 ADRENAL INSUFFICIENCY 66 0.0054
582 SKIN INFECTION 61 0.0054
583 CYTOKINE RELEASE SYNDROME 109 0.0054
584 TOXICITY TO VARIOUS AGENTS 907 0.0054
585 FACE OEDEMA 90 0.0053
586 PERIPHERAL COLDNESS 73 0.0053
587 SUBARACHNOID HAEMORRHAGE 54 0.0053
588 SALIVARY HYPERSECRETION 53 0.0053
589 HEMIPLEGIA 44 0.0053
590 RENAL CYST 42 0.0053
591 PAPULE 37 0.0052
592 CARDIAC ARREST 432 0.0052
593 ENCEPHALITIS 36 0.0052
594 UPPER GASTROINTESTINAL HAEMORRHAGE 87 0.0052
595 ANAL INCONTINENCE 46 0.0051
596 HYPOTHYROIDISM 163 0.0051
597 HEMIPARESIS 86 0.0051
598 CHEST PAIN 934 0.0050
599 POSTOPERATIVE WOUND INFECTION 34 0.0050
600 GASTROINTESTINAL HAEMORRHAGE 420 0.0050
601 DEPRESSED LEVEL OF CONSCIOUSNESS 198 0.0050
602 HEPATOMEGALY 49 0.0050
603 ANAPHYLACTIC REACTION 275 0.0050
604 OSTEONECROSIS 163 0.0050
605 GASTRIC HAEMORRHAGE 57 0.0049
606 INFECTION 716 0.0049
607 IMPAIRED QUALITY OF LIFE 71 0.0049
608 LUNG DISORDER 241 0.0049
609 MOUTH HAEMORRHAGE 36 0.0049
610 TOOTH EXTRACTION 61 0.0049
611 ATAXIA 58 0.0049
612 GASTRITIS 128 0.0049
613 SENSORY LOSS 39 0.0048
614 LIVER DISORDER 214 0.0048
615 MOTOR DYSFUNCTION 49 0.0048
616 RED BLOOD CELL COUNT DECREASED 137 0.0048
617 ARRHYTHMIA 226 0.0048
618 HAEMODIALYSIS 40 0.0048
619 ATRIAL FLUTTER 38 0.0048
620 PHARYNGITIS 59 0.0048
621 DRUG ERUPTION 84 0.0047
622 SYNCOPE 472 0.0047
623 TORSADE DE POINTES 37 0.0047
624 CONSTIPATION 1027 0.0047
625 ABDOMINAL PAIN LOWER 119 0.0047
626 DYSPNOEA EXERTIONAL 177 0.0047
627 ERYTHEMA 965 0.0047
628 HAEMATOCHEZIA 259 0.0047
629 SKIN ULCER 121 0.0047
630 BASAL CELL CARCINOMA 73 0.0047
631 IMPAIRED HEALING 153 0.0047
632 TRICUSPID VALVE INCOMPETENCE 37 0.0047
633 PERICARDITIS 78 0.0046
634 OXYGEN SATURATION DECREASED 259 0.0046
635 PULMONARY HAEMORRHAGE 36 0.0046
636 AORTIC ANEURYSM 35 0.0046
637 APPLICATION SITE ERYTHEMA 120 0.0046
638 URINE OUTPUT DECREASED 40 0.0046
639 DYSPHONIA 267 0.0046
640 OEDEMA 247 0.0045
641 DEVICE OCCLUSION 64 0.0045
642 PSYCHOLOGICAL TRAUMA 39 0.0045
643 RESPIRATORY RATE INCREASED 40 0.0045
644 URINARY RETENTION 150 0.0045
645 THROAT TIGHTNESS 121 0.0045
646 MENTAL STATUS CHANGES 124 0.0045
647 HAEMODYNAMIC INSTABILITY 34 0.0045
648 LUNG INFECTION 69 0.0044
649 ALOPECIA 872 0.0044
650 TUBULOINTERSTITIAL NEPHRITIS 83 0.0044
651 COLD SWEAT 78 0.0044
652 DRUG INTOLERANCE 426 0.0044
653 HAEMORRHOIDS 86 0.0044
654 GINGIVAL PAIN 35 0.0044
655 OEDEMA PERIPHERAL 533 0.0044
656 HAEMORRHAGIC STROKE 34 0.0043
657 ACUTE HEPATIC FAILURE 59 0.0043
658 PSEUDOMONAS INFECTION 37 0.0043
659 CARDIOMEGALY 53 0.0043
660 INFLAMMATION 222 0.0043
661 THROMBOSIS 346 0.0043
662 GASTROINTESTINAL DISORDER 385 0.0043
663 DYSGEUSIA 318 0.0043
664 LACRIMATION INCREASED 129 0.0043
665 EMPHYSEMA 43 0.0043
666 FATIGUE 3318 0.0043
667 RETINAL DETACHMENT 39 0.0042
668 HYPERSENSITIVITY 778 0.0042
669 LETHARGY 240 0.0042
670 COMA 197 0.0041
671 OFF LABEL USE 3620 0.0041
672 DYSURIA 152 0.0041
673 HAEMORRHAGE 430 0.0041
674 RHINITIS 33 0.0041
675 PHOTOSENSITIVITY REACTION 67 0.0041
676 DIABETIC KETOACIDOSIS 97 0.0040
677 CLOSTRIDIUM DIFFICILE INFECTION 88 0.0040
678 BLOOD DISORDER 32 0.0040
679 DISORIENTATION 158 0.0040
680 HYPOAESTHESIA ORAL 60 0.0040
681 PULMONARY OEDEMA 178 0.0040
682 IMMUNOSUPPRESSION 35 0.0040
683 HYPOTHERMIA 40 0.0039
684 PNEUMONIA 1279 0.0039
685 APPLICATION SITE PAIN 87 0.0039
686 PRODUCT USE IN UNAPPROVED INDICATION 976 0.0039
687 OSTEOMYELITIS 71 0.0039
688 COLORECTAL CANCER 187 0.0039
689 UNRESPONSIVE TO STIMULI 101 0.0039
690 TRANSIENT ISCHAEMIC ATTACK 132 0.0039
691 SKIN EXFOLIATION 330 0.0039
692 NEURALGIA 95 0.0039
693 BONE DISORDER 71 0.0039
694 TASTE DISORDER 79 0.0039
695 WEIGHT DECREASED 1076 0.0039
696 CELLULITIS 192 0.0038
697 PULMONARY HYPERTENSION 79 0.0038
698 IRON DEFICIENCY ANAEMIA 35 0.0038
699 POST PROCEDURAL HAEMORRHAGE 44 0.0038
700 APPENDICITIS 35 0.0037
701 DELIRIUM 129 0.0037
702 HAEMOPTYSIS 103 0.0037
703 SPUTUM DISCOLOURED 35 0.0037
704 STEVENS-JOHNSON SYNDROME 82 0.0037
705 INTERNATIONAL NORMALISED RATIO INCREASED 105 0.0037
706 LACTIC ACIDOSIS 119 0.0037
707 DYSPNOEA 2055 0.0036
708 RASH 1571 0.0036
709 EATING DISORDER 76 0.0036
710 BODY TEMPERATURE DECREASED 35 0.0036
711 SENSORY DISTURBANCE 57 0.0035
712 TRANSFUSION 37 0.0035
713 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 251 0.0035
714 OPTIC NEURITIS 32 0.0035
715 HYPERTHYROIDISM 50 0.0035
716 PULMONARY ARTERIAL HYPERTENSION 50 0.0034
717 IMMUNODEFICIENCY 51 0.0034
718 GENERALISED TONIC-CLONIC SEIZURE 56 0.0034
719 GASTROINTESTINAL PAIN 37 0.0034
720 FEEDING DISORDER 68 0.0033
721 COGNITIVE DISORDER 156 0.0033
722 HIP ARTHROPLASTY 51 0.0033
723 OBSTRUCTIVE AIRWAYS DISORDER 37 0.0033
724 TREATMENT FAILURE 274 0.0033
725 FLUSHING 335 0.0033
726 DIVERTICULITIS 91 0.0033
727 URINARY TRACT INFECTION 555 0.0033
728 SPEECH DISORDER 170 0.0032
729 EPILEPSY 99 0.0032
730 DEAFNESS 84 0.0032
731 HYPERHIDROSIS 413 0.0032
732 LOSS OF CONSCIOUSNESS 409 0.0032
733 BLOOD PRESSURE DECREASED 212 0.0032
734 DRY SKIN 423 0.0032
735 PANCREATITIS 167 0.0032
736 IMPAIRED GASTRIC EMPTYING 43 0.0032
737 NEOPLASM 36 0.0031
738 CEREBRAL HAEMORRHAGE 112 0.0031
739 MASS 43 0.0031
740 URINARY INCONTINENCE 91 0.0031
741 COVID-19 PNEUMONIA 36 0.0030
742 HYPOAESTHESIA 454 0.0030
743 ELECTROCARDIOGRAM QT PROLONGED 109 0.0030
744 INCONTINENCE 32 0.0030
745 HYPERLIPIDAEMIA 36 0.0030
746 PRESYNCOPE 73 0.0030
747 BRADYCARDIA 159 0.0030
748 HEPATIC CIRRHOSIS 56 0.0030
749 SWOLLEN TONGUE 93 0.0030
750 FEELING HOT 180 0.0029
751 LIVER FUNCTION TEST ABNORMAL 85 0.0029
752 BONE PAIN 171 0.0029
753 RESPIRATORY TRACT INFECTION 76 0.0029
754 PLATELET COUNT INCREASED 38 0.0029
755 NODULE 38 0.0029
756 CHEST DISCOMFORT 297 0.0029
757 DENTAL CARIES 32 0.0029
758 THERAPY NON-RESPONDER 130 0.0029
759 PRODUCT PRESCRIBING ISSUE 63 0.0029
760 EAR PAIN 56 0.0029
761 ABDOMINAL DISTENSION 300 0.0029
762 CONVULSION 164 0.0029
763 RASH ERYTHEMATOUS 137 0.0029
764 DERMATITIS ALLERGIC 36 0.0029
765 BRAIN OEDEMA 36 0.0028
766 NEOPLASM MALIGNANT 190 0.0028
767 CORONARY ARTERY DISEASE 86 0.0028
768 CONFUSIONAL STATE 458 0.0028
769 PAIN IN JAW 80 0.0028
770 ORAL HERPES 55 0.0028
771 DIPLOPIA 73 0.0028
772 ABDOMINAL PAIN UPPER 576 0.0028
773 CONDITION AGGRAVATED 836 0.0027
774 BACK PAIN 633 0.0027
775 MALAISE 1194 0.0027
776 SKIN HAEMORRHAGE 40 0.0027
777 RETCHING 57 0.0027
778 LIP SWELLING 89 0.0027
779 PHARYNGEAL OEDEMA 41 0.0027
780 FEELING COLD 74 0.0027
781 PULMONARY CONGESTION 35 0.0027
782 DYSPEPSIA 258 0.0026
783 DIALYSIS 37 0.0026
784 PREMATURE BABY 78 0.0026
785 DRUG INTERACTION 410 0.0026
786 MUSCULAR WEAKNESS 293 0.0026
787 RASH PAPULAR 57 0.0025
788 ORAL DISCOMFORT 35 0.0025
789 AMENORRHOEA 44 0.0025
790 CARDIAC FAILURE CONGESTIVE 201 0.0025
791 MUSCULOSKELETAL PAIN 130 0.0025
792 DRY MOUTH 201 0.0025
793 SKIN CANCER 53 0.0025
794 BLISTER 137 0.0024
795 HEPATIC ENZYME INCREASED 166 0.0024
796 MUSCLE TWITCHING 56 0.0024
797 BRAIN FOG 38 0.0024
798 BLOOD TEST ABNORMAL 34 0.0024
799 CHOLELITHIASIS 79 0.0024
800 BLOOD POTASSIUM INCREASED 39 0.0024
801 MUSCULOSKELETAL CHEST PAIN 37 0.0024
802 HEART RATE IRREGULAR 54 0.0024
803 RASH MACULAR 83 0.0024
804 MYOCARDIAL INFARCTION 413 0.0024
805 DEATH 2025 0.0023
806 RHINORRHOEA 151 0.0023
807 OROPHARYNGEAL PAIN 215 0.0023
808 PANCREATIC CARCINOMA 67 0.0023
809 HERPES ZOSTER 133 0.0023
810 THERAPEUTIC RESPONSE DECREASED 140 0.0023
811 CHROMATURIA 52 0.0023
812 COUGH 643 0.0023
813 SEIZURE 263 0.0023
814 HAEMORRHAGE INTRACRANIAL 34 0.0023
815 COMPLICATION ASSOCIATED WITH DEVICE 33 0.0023
816 PAIN OF SKIN 61 0.0023
817 GASTRIC CANCER 57 0.0022
818 CYTOMEGALOVIRUS INFECTION 37 0.0022
819 FAECES DISCOLOURED 48 0.0022
820 SWELLING FACE 144 0.0022
821 NERVOUS SYSTEM DISORDER 69 0.0022
822 HYPOGLYCAEMIA 107 0.0022
823 HAEMATOMA 57 0.0022
824 FUNGAL INFECTION 73 0.0022
825 FULL BLOOD COUNT DECREASED 44 0.0022
826 DRUG LEVEL INCREASED 36 0.0022
827 AGEUSIA 54 0.0022
828 SCAR 37 0.0022
829 BLOOD PRESSURE INCREASED 330 0.0022
830 BLOOD CREATINE PHOSPHOKINASE INCREASED 62 0.0022
831 PREMATURE DELIVERY 34 0.0021
832 GLOSSODYNIA 47 0.0021
833 FLATULENCE 119 0.0021
834 LIVER FUNCTION TEST INCREASED 45 0.0021
835 BREAST CANCER 195 0.0021
836 CEREBROVASCULAR ACCIDENT 351 0.0021
837 ANGIOEDEMA 91 0.0021
838 LOWER RESPIRATORY TRACT INFECTION 93 0.0020
839 PRODUCTIVE COUGH 97 0.0020
840 PHOTOPHOBIA 38 0.0020
841 CARDIOVASCULAR DISORDER 51 0.0020
842 FRACTURE 38 0.0020
843 GASTROENTERITIS VIRAL 36 0.0020
844 SKIN DISCOLOURATION 91 0.0020
845 RESPIRATORY DISORDER 59 0.0020
846 PRURITUS 748 0.0019
847 RESTLESSNESS 71 0.0019
848 BLINDNESS 79 0.0019
849 DIZZINESS 952 0.0019
850 VERTIGO 116 0.0019
851 PAIN 1168 0.0019
852 FREQUENT BOWEL MOVEMENTS 51 0.0019
853 UPPER RESPIRATORY TRACT INFECTION 87 0.0019
854 TINNITUS 86 0.0019
855 HOT FLUSH 141 0.0019
856 POLLAKIURIA 78 0.0019
857 ERUCTATION 36 0.0019
858 WOUND 52 0.0019
859 BURNING SENSATION 130 0.0019
860 THIRST 33 0.0018
861 INCORRECT PRODUCT ADMINISTRATION DURATION 40 0.0018
862 HEART RATE INCREASED 181 0.0018
863 BLOOD PRESSURE SYSTOLIC INCREASED 35 0.0018
864 CYSTITIS 57 0.0018
865 NECK PAIN 100 0.0018
866 RASH PRURITIC 96 0.0018
867 ILL-DEFINED DISORDER 107 0.0018
868 ACNE 131 0.0017
869 APPLICATION SITE PRURITUS 39 0.0017
870 ACTIVITIES OF DAILY LIVING IMPAIRED 34 0.0017
871 DRUG INEFFECTIVE 2247 0.0017
872 PRODUCT ADMINISTRATION ERROR 34 0.0017
873 THROAT IRRITATION 75 0.0017
874 RASH GENERALISED 43 0.0017
875 VISUAL ACUITY REDUCED 55 0.0017
876 MUSCLE SPASMS 302 0.0016
877 INTENTIONAL PRODUCT USE ISSUE 144 0.0016
878 TREMOR 272 0.0016
879 DYSSTASIA 47 0.0016
880 AGITATION 117 0.0016
881 DIABETES MELLITUS 121 0.0016
882 FALL 526 0.0016
883 TOOTH DISORDER 35 0.0016
884 GASTROOESOPHAGEAL REFLUX DISEASE 126 0.0016
885 GAIT DISTURBANCE 297 0.0016
886 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 85 0.0015
887 PALPITATIONS 180 0.0015
888 MYALGIA 259 0.0015
889 FEMUR FRACTURE 47 0.0015
890 PRODUCT PRESCRIBING ERROR 36 0.0015
891 ECZEMA 79 0.0015
892 OSTEOPOROSIS 62 0.0015
893 SKIN IRRITATION 69 0.0015
894 MATERNAL EXPOSURE DURING PREGNANCY 132 0.0015
895 SKIN BURNING SENSATION 105 0.0015
896 CARDIAC DISORDER 137 0.0015
897 EMOTIONAL DISORDER 44 0.0014
898 DISCOMFORT 87 0.0014
899 ARTHROPATHY 79 0.0014
900 SURGERY 83 0.0014
901 RESPIRATORY ARREST 39 0.0014
902 PRODUCT USE ISSUE 265 0.0014
903 VAGINAL HAEMORRHAGE 61 0.0014
904 COVID-19 246 0.0014
905 EYE SWELLING 52 0.0014
906 CHRONIC KIDNEY DISEASE 106 0.0014
907 RENAL DISORDER 65 0.0014
908 HYPOACUSIS 60 0.0014
909 LABORATORY TEST ABNORMAL 41 0.0014
910 PERIPHERAL SWELLING 213 0.0014
911 PAIN IN EXTREMITY 400 0.0014
912 CONTRAINDICATED PRODUCT ADMINISTERED 41 0.0014
913 OESOPHAGEAL CARCINOMA 40 0.0013
914 INFLUENZA LIKE ILLNESS 111 0.0013
915 SOMNOLENCE 267 0.0013
916 FOETAL EXPOSURE DURING PREGNANCY 107 0.0013
917 SWELLING 123 0.0013
918 ADVERSE EVENT 121 0.0013
919 BRONCHITIS 97 0.0013
920 OCULAR HYPERAEMIA 62 0.0013
921 EYE IRRITATION 75 0.0013
922 URTICARIA 218 0.0013
923 GAIT INABILITY 43 0.0013
924 BALANCE DISORDER 111 0.0013
925 SLEEP DISORDER 89 0.0013
926 CATARACT 74 0.0012
927 DRY EYE 62 0.0012
928 RHABDOMYOLYSIS 51 0.0012
929 DRUG EFFECT INCOMPLETE 44 0.0012
930 HEADACHE 753 0.0012
931 NEPHROLITHIASIS 55 0.0012
932 ADVERSE DRUG REACTION 106 0.0012
933 DEPRESSED MOOD 62 0.0012
934 INSOMNIA 312 0.0012
935 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 56 0.0012
936 HIP FRACTURE 37 0.0011
937 THERAPY CESSATION 59 0.0011
938 NIGHT SWEATS 37 0.0011
939 VISION BLURRED 157 0.0011
940 MEDICATION ERROR 63 0.0011
941 VISUAL IMPAIRMENT 140 0.0011
942 RENAL INJURY 33 0.0011
943 TREATMENT NONCOMPLIANCE 60 0.0011
944 ACCIDENTAL OVERDOSE 40 0.0011
945 DYSKINESIA 44 0.0011
946 ARTHRALGIA 447 0.0011
947 OSTEOARTHRITIS 44 0.0010
948 HEART RATE DECREASED 36 0.0010
949 EXPOSURE DURING PREGNANCY 63 0.0010
950 ABDOMINAL DISCOMFORT 170 0.0010
951 DEVICE DISLOCATION 44 0.0010
952 MUSCULOSKELETAL STIFFNESS 88 0.0010
953 THERAPY INTERRUPTED 71 0.0010
954 HALLUCINATION 74 0.0010
955 DISTURBANCE IN ATTENTION 52 0.0010
956 VIRAL INFECTION 32 0.0010
957 BLOOD GLUCOSE INCREASED 180 0.0010
958 ANXIETY 270 0.0009
959 EYE PAIN 53 0.0009
960 WHEEZING 55 0.0009
961 NASOPHARYNGITIS 168 0.0009
962 MOBILITY DECREASED 65 0.0009
963 AMNESIA 58 0.0009
964 NASAL CONGESTION 52 0.0009
965 DEPRESSION 199 0.0009
966 CONTUSION 82 0.0009
967 ASTHMA 96 0.0008
968 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 153 0.0008
969 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 44 0.0008
970 COLITIS ULCERATIVE 37 0.0008
971 UNEVALUABLE EVENT 62 0.0008
972 LUNG NEOPLASM MALIGNANT 33 0.0008
973 MEMORY IMPAIRMENT 106 0.0008
974 FEELING ABNORMAL 181 0.0008
975 ARTHRITIS 55 0.0007
976 SINUSITIS 70 0.0007
977 IRRITABILITY 41 0.0007
978 OVERDOSE 147 0.0007
979 WEIGHT INCREASED 151 0.0007
980 UNDERDOSE 49 0.0007
981 JOINT SWELLING 81 0.0007
982 INFLUENZA 73 0.0007
983 ILLNESS 66 0.0006
984 EMOTIONAL DISTRESS 66 0.0005
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 35 0.0005
986 ACCIDENTAL EXPOSURE TO PRODUCT 50 0.0005
987 MIGRAINE 40 0.0004
988 NO ADVERSE EVENT 61 0.0003
989 PRODUCT DOSE OMISSION ISSUE 88 0.0003
990 PSORIASIS 39 0.0003
991 HOSPITALISATION 45 0.0003
992 INJECTION SITE ERYTHEMA 32 0.0003
993 PRODUCT QUALITY ISSUE 34 0.0003
994 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 49 0.0002
995 INCORRECT DOSE ADMINISTERED 55 0.0002
996 INJECTION SITE PAIN 42 0.0001